期刊： LEUKEMIA RESEARCH, 2022; 115 ()
The aim of study was to assess the clinical characteristics, survival outcomes of newly diagnosed multiple myeloma (NDMM) patients with extramedullary......
期刊： LEUKEMIA RESEARCH, 2022; 118 ()
More than 90% of NPM1-mutated acute myeloid leukaemia (NPM1mut AML) patients have been determined to harbour other known concurrent mutations. However......
期刊： LEUKEMIA RESEARCH, 2022; 114 ()
Background: Information on the outcomes and treatments of early-stage (I/II) primary cutaneous marginal zone lymphoma (PCMZL) is limited. This study a......
期刊： LEUKEMIA RESEARCH, 2022; 122 ()
Multiple myeloma (MM) remains an incurable hematologic malignancy due to its frequent drug resistance and relapse. Cluster of Differentiation 47 (CD47......
期刊： LEUKEMIA RESEARCH, 2022; 117 ()
Little is known regarding whether the cell of origin differs among different leukemia types. To address this fundamental issue, we determined the cell......
期刊： LEUKEMIA RESEARCH, 2022; 112 ()
Diffuse large B cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma worldwide, is aggressive and highly heterogeneous. MiR-665 was fou......
期刊： LEUKEMIA RESEARCH, 2022; 120 ()
Factor X (FX) deficiency is prevalent in light-chain (AL) amyloidosis but its clinical significance was not investigated deeply. We conducted a retros......
期刊： LEUKEMIA RESEARCH, 2022; 118 ()
Purpose: To explore the best treatment for early natural killer/T (NK/T)-cell lymphoma, we compared the efficacy and safety of DDGP (pegaspargase, gem......
期刊： LEUKEMIA RESEARCH, 2022; 123 ()
Background: This study aimed to retrospectively evaluate a large Chinese cohort's baseline characters and develop a new predictive scoring system. Met......
期刊： LEUKEMIA RESEARCH, 2022; 123 ()
Background: Bortezomib resistance hampers the long-term survival of multiple myeloma (MM) patients. Our previous study has proved that downregulated l......
期刊： LEUKEMIA RESEARCH, 2022; 120 ()
Background: Deregulated expression of miRNAs contributes to the development of numerous malignancies, including acute myeloid leukemia (AML). The pres......
期刊： LEUKEMIA RESEARCH, 2022; 113 ()
Background: Circular RNAs (circRNAs) have been reported to play critical roles in the malignant progression of diverse human cancers, including multip......
期刊： LEUKEMIA RESEARCH, 2022; 114 ()
Objective: This study investigated the mechanism by which miR-197-3p regulated IL-6 expression and reduced bortezomib (BTZ) resistance in multiple mye......
期刊： LEUKEMIA RESEARCH, 2022; 117 ()
Background: CD5 expression in different B-cell lymphomas has different clinicopathological and prognosis and the value of CD5 expression in marginal z......
期刊： LEUKEMIA RESEARCH, 2022; 120 ()
Acute megakaryoblastic leukaemia (AMKL) is characterized by expansion of megakaryoblasts, which are hyper -proliferative cells that fail to undergo di......
